{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-24-000058","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.661500+00:00","generated_at":"2026-05-31T07:18:14.812867+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CooperCompanies Q3 revenue up 8% to $1,002.8M; raises FY 2024 guidance","bullets":["Revenue $1,002.8M (+8% YoY); GAAP diluted EPS $0.52 (+22%), non-GAAP diluted EPS $0.96 (+14%).","CooperVision revenue $675.6M (+7% YoY); CooperSurgical $327.2M (+9%).","FY2024 guidance raised: revenue $3,892-$3,913M, non-GAAP EPS $3.64-$3.67.","Q4 FY2024 guidance: revenue $1,015-$1,036M, non-GAAP EPS $0.98-$1.01.","Operating cash flow $207.5M; free cash flow $118.5M; GAAP gross margin 66%, non-GAAP 67%."],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-24-000058","json":"https://secwatch.observer/filing/0000711404-24-000058.json","markdown":"https://secwatch.observer/filing/0000711404-24-000058.md","text":"https://secwatch.observer/filing/0000711404-24-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140424000058/0000711404-24-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140424000058/coo-20240828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:18:14.812867+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}